Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Lupus
|
August 13, 2009
European registry of babies born to mothers with antiphospholipid syndrome: a result update
M-C Boffa, E Lachassinne, C Boinot, et al.
Mutation Research
|
February 3, 2007
Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma
L C Boffa, P Menichini, C Bolognesi, et al.
Minerva Pediatrica
|
November 25, 2010
European registry of infants born to mothers with antiphospholipid syndrome: preliminary results
M Motta, E Lachassinne, M C Boffa, et al.
Cancer Gene Therapy
|
April 14, 2009
PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease
S Matis, M R Mariani, G Cutrona, et al.
Lupus
|
October 16, 2004
European register of babies born to mothers with antiphospholipid syndrome
M C Boffa, M H Aurousseau, E Lachassinne, et al.
British Journal of Cancer
|
June 28, 2002
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
G Cutrona, P Tasso, M Dono, et al.
Rheumatology (Oxford, England)
|
June 10, 2011
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study
Amelia Ruffatti, Marta Tonello, Maria S Visentin, et al.
Journal of Clinical Immunology
|
November 7, 2003
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome
Y Shoenfeld, I Krause, F Kvapil, et al.
Annals of the Rheumatic Diseases
|
September 20, 2008
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
R Cervera, M A Khamashta, Y Shoenfeld, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Lupus
|
August 13, 2009
European registry of babies born to mothers with antiphospholipid syndrome: a result update
M-C Boffa, E Lachassinne, C Boinot, et al.
Mutation Research
|
February 3, 2007
Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma
L C Boffa, P Menichini, C Bolognesi, et al.
Minerva Pediatrica
|
November 25, 2010
European registry of infants born to mothers with antiphospholipid syndrome: preliminary results
M Motta, E Lachassinne, M C Boffa, et al.
Cancer Gene Therapy
|
April 14, 2009
PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease
S Matis, M R Mariani, G Cutrona, et al.
Lupus
|
October 16, 2004
European register of babies born to mothers with antiphospholipid syndrome
M C Boffa, M H Aurousseau, E Lachassinne, et al.
British Journal of Cancer
|
June 28, 2002
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
G Cutrona, P Tasso, M Dono, et al.
Rheumatology (Oxford, England)
|
June 10, 2011
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study
Amelia Ruffatti, Marta Tonello, Maria S Visentin, et al.
Journal of Clinical Immunology
|
November 7, 2003
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome
Y Shoenfeld, I Krause, F Kvapil, et al.
Annals of the Rheumatic Diseases
|
September 20, 2008
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
R Cervera, M A Khamashta, Y Shoenfeld, et al.
Page
of 11